Roulot, Dominique <br/><br/>
Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  03 2018 
 - 302-309 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0000000000001035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--adverse effects<br/>Carbamates<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--classification<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Imidazoles--adverse effects<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Isoquinolines--adverse effects<br/>Liver Cirrhosis--virology<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Pyrrolidines<br/>RNA, Viral--blood<br/>Recombinant Proteins--adverse effects<br/>Ribavirin--adverse effects<br/>Sulfonamides--adverse effects<br/>Sustained Virologic Response<br/>Treatment Failure<br/>Treatment Outcome<br/>Valine--analogs & derivatives<br/>Viral Load--drug effects